Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Urologic oncology

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.urolonc.2016.10.019PMID 27890424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miRNAs as novel biomarkers in the management of prostate cancer

  2017cited by this paper
• MicroRNA epigenetic signatures in human disease

  2016cited by this paper
• MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer

  2016cited by this paper
• A circulating miRNA assay as a first-line test for prostate cancer screening

  2016cited by this paper
• Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review

  2016cited by this paper
• Syndecan‐1 up‐regulates microRNA‐331‐3p and mediates epithelial‐to‐mesenchymal transition in prostate cancer

  2016cited by this paper
• Detection of miRNAs in urine of prostate cancer patients.

  2016cited by this paper
• microRNAs as cancer biomarkers

  2016cited by this paper
• Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer

  2016cited by this paper
• The roles of microRNAs in the progression of castration-resistant prostate cancer

  2016cited by this paper
• Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status

  2016cited by this paper
• A predictive signature for therapy assignment and risk assessment in prostate cancer

  2015cited by this paper
• Do prostate cancer nomograms give accurate information when applied to European patients?

  2015cited by this paper
• Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs

  2014cited by this paper
• MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1

  2014cited by this paper
• miR‐20a Promotes Prostate Cancer Invasion and Migration Through Targeting ABL2

  2014cited by this paper
• ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

  2014cited by this paper
• AR function in promoting metastatic prostate cancer

  2014cited by this paper
• Prostate specific antigen best practice statement: 2009 update.

  2013cited by this paper
• PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.

  2013cited by this paper
• A complex Polycomb issue: the two faces of EZH2 in cancer.

  2012cited by this paper
• Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer

  2012cited by this paper
• Changes in circulating microRNA levels associated with prostate cancer

  2012cited by this paper
• microRNAs in cancer management.

  2012cited by this paper
• A 'pivotal' new rule for microRNA-mRNA interactions

  2012cited by this paper
• Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.

  2012cited by this paper
• Suppression of CX43 expression by miR-20a in the progression of human prostate cancer

  2012cited by this paper
• Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease

  2012cited by this paper
• MicroRNA Response Elements-Mediated miRNA-miRNA Interactions in Prostate Cancer

  2012cited by this paper
• miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways

  2012cited by this paper
• Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms

  2011cited by this paper
• Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.

  2011cited by this paper
• Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

  2011cited by this paper
• MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression

  2011cited by this paper
• Identification of miRs-143 and -145 that Is Associated with Bone Metastasis of Prostate Cancer and Involved in the Regulation of EMT

  2011cited by this paper
• Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.

  2011cited by this paper
• Serum miRNA‐21: Elevated levels in patients with metastatic hormone‐refractory prostate cancer and potential predictive factor for the efficacy of docetaxel‐based chemotherapy

  2011cited by this paper
• Circulating miRNAs are correlated with tumor progression in prostate cancer

  2011cited by this paper
• Coordinated regulation of polycomb group complexes through microRNAs in cancer.

  2011cited by this paper
• Circulating microRNAs (miRNA) in serum of patients with prostate cancer.

  2011cited by this paper
• The CAPRA‐S score

  2011cited by this paper
• The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing

  2010cited by this paper
• microRNAs: a newly described class of encoded molecules that play a role in health and disease.

  2010cited by this paper
• A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

  2010cited by this paper
• MicroRNA: Biogenesis, Function and Role in Cancer

  2010cited by this paper
• The transcriptional regulation of miR-21, its multiple transcripts and their implication in prostate cancer

  2010cited by this paper
• MicroRNA profile analysis of human prostate cancers

  2009cited by this paper
• MicroRNAs in Cancer.

  2009cited by this paper
• The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.

  2009cited by this paper
• MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells

  2009cited by this paper
• Prostate specific antigen best practice statement: 2009 update.

  2009cited by this paper
• Screening and prostate-cancer mortality in a randomized European study.

  2009cited by this paper
• Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

  2009cited by this paper
• Prostate specific antigen through the years.

  2009cited by this paper
• microRNAs and prostate cancer

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Control of protein synthesis and mRNA degradation by microRNAs.

  2008cited by this paper
• Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.

  2008cited by this paper
• The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.

  2008cited by this paper
• The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

  2008cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• Repression of protein synthesis by miRNAs: how many mechanisms?

  2007cited by this paper
• microRNA functions.

  2007cited by this paper
• MicroRNA expression profiling in prostate cancer.

  2007cited by this paper
• Why Current Breast Pathology Practices Must Be Evaluated. A Susan G. Komen for the Cure White Paper: June 2006

  2007cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

  2006cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• Function of nuclear sex hormone receptors in gene regulation

  2005cited by this paper
• The Drosha-DGCR8 complex in primary microRNA processing.

  2004cited by this paper
• Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

  2004cited by this paper
• Molecular determinants of resistance to antiandrogen therapy

  2004cited by this paper
• The functions of animal microRNAs

  2004cited by this paper
• Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs

  2004cited by this paper
• The nuclear RNase III Drosha initiates microRNA processing

  2003cited by this paper
• A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA

  2001cited by this paper
• Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.

  1993cited by this paper
• The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

  1993cited by this paper

• CRISPR/Cas12a-Based Biosensing: Advances in Mechanisms and Applications for Nucleic Acid Detection

  2025cites this paper
• Construction of a light-up multicolor fluorescent aptasensor for simultaneous measurement of multiple miRNAs in breast cancer tissues

  2025cites this paper
• CRISPR/Cas12a-mediated DNA-AgNC label-free logical gate for multiple microRNAs’ assay

  2024cites this paper
• Expression of stem cell markers as predictors of therapeutic response in metastatic prostate cancer patients.

  2024cites this paper
• CRISPR/Cas12a-Powered Electrochemical Platform for Dual-miRNA Detection via an AND Logic Circuit.

  2024cites this paper
• Deregulation of miR-10b and miR-21 Correlate with Cancer Stem Cells Expansion through the Apoptotic Pathway in Prostate Cancer

  2023cites this paper
• Epigenetics regulation of prostate cancer: Biomarker and therapeutic potential.

  2023cites this paper
• Inhibition of miR-20a by pterostilbene facilitates prostate cancer cells killed by NK cells via up-regulation of NKG2D ligands and TGF-β1down-regulation.

  2023cites this paper
• Cascade-Amplified Fluorescence Polarization Assay for MiRNA Based on Aggregation Strategy of Y-Shaped DNA

  2023cites this paper
• Self-Generation of Distinguishable Fluorescent Probes via a One-Pot Process for Multiple MicroRNA Detection by Liquid Chromatography.

  2023cites this paper
• A cascade signal-amplified fluorescent biosensor combining APE1 enzyme cleavage-assisted target cycling with rolling circle amplification.

  2023cites this paper
• Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics.

  2023cites this paper
• Enzyme-assisted amplification of target cycle triggers the unlocking of locked hairpin probes for let-7a detection.

  2023cites this paper
• miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer

  2023cites this paper
• Current Trends in Prevalence and Role of Long Noncoding RNA and Gene Fusion in Prostate Cancer: An Overview

  2021cites this paper
• miR-361-5p regulates ovarian cancer cell proliferation and apoptosis by targeting TRAF3

  2021cites this paper
• A four-genes based diagnostic signature for osteoarthritis

  2021cites this paper
• Recent advances in the detection of multiple microRNAs

  2021cites this paper
• Seminal exosomes – An important biological marker for various disorders and syndrome in human reproduction

  2021cites this paper
• MicroRNA panel in serum reveals novel diagnostic biomarkers for prostate cancer

  2021cites this paper
• Benefits and pitfalls: Epigenetic modulators in prostate cancer intervention

  2021cites this paper
• Framework nucleic acid programmed combinatorial delivery nanocarriers for parallel and multiplexed analysis.

  2021cites this paper
• Effect of miR-188-5p on growth and metastasis of prostate cancer cells

  2020cites this paper
• CMAR_A_260542 6137..6147

  2020cites this paper
• Cationic Polymer Nanoparticles-Mediated Delivery of miR-124 Impairs Tumorigenicity of Prostate Cancer Cells

  2020cites this paper
• Recent scenario of long non-coding RNAs as a diagnostic and prognostic biomarkers of prostate cancer.

  2020cites this paper
• MiR-887-3p Negatively Regulates STARD13 and Promotes Pancreatic Cancer Progression

  2020cites this paper
• The Expression of Different Micrornas in Iraqi Patients with Childhood Acute Leukemia and Their Association to C/EBP-Î’ Serum Level

  2020cites this paper
• Recent Advances in Molecular Diagnostic Approaches for Cancer

  2019cites this paper
• Ionizing radiation affects miRNA composition in both young and old mice

  2019cites this paper
• Novel Diagnostic Biomarkers of Prostate Cancer: An Update.

  2019cites this paper
• MicroRNA-16 inhibits migration and invasion via regulation of the Wnt/β-catenin signaling pathway in ovarian cancer

  2019cites this paper
• Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13

  2019cites this paper
• A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer

  2018cites this paper
• Candidate diagnostic miRNAs that can detect cancer in prostate biopsy

  2018influential citation
• MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential

  2018cites this paper
• Evaluation of a 3-base pair indel polymorphism within pre-microRNA-3131 in patients with prostate cancer using mismatch polymerase chain reaction-restriction fragment length polymorphism.

  2017cites this paper
• Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?

  2017cites this paper
• Association between Polymorphisms in MicroRNAs and Risk of Urological Cancer: A Meta-Analysis Based on 17,019 Subjects

  2017cites this paper
• Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs

  2017cites this paper
• Circulating cell-free microRNAs as clinical cancer biomarkers

  2017cites this paper
• Exploiting Epigenetic Alterations in Prostate Cancer

  2017cites this paper
• 3-bp indel polymorphism (rs57408770) within pre-miR-3131 on PCa susceptibility in a sample of an Iranian population. Patients and methods

  2017cites this paper
• Circulating cell-free microRNAs as clinical cancer biomarkers.

  2017cites this paper
• miR-518f-5p decreases tetraspanin CD9 protein levels and differentially affects non-tumourigenic prostate and prostate cancer cell migration and adhesion

  2017cites this paper